Selected research
Industry Research
Peptide CRO Services Industry Research Report 2026
Market perspective
The global Peptide CRO Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Peptide CRO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Peptide CRO Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Peptide CRO Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Peptide CRO Services include IMED Bioscience, Peptites Biotech, Genevoyager, Viva Biotech, Space Peptides Pharmaceutical, Motif Biotechnology, JYMed Technology, GenScript and TriApex Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Peptide CRO Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Peptide CRO Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peptide CRO Services Market by Company
IMED Bioscience
Peptites Biotech
Genevoyager
Viva Biotech
Space Peptides Pharmaceutical
Motif Biotechnology
JYMed Technology
GenScript
TriApex Laboratories
Go Top Peptide Biotech
Sun-Novo Pharmaceutical Research
Thermo Fisher
Syngene
Svar Life Science
PolyPeptide
PeptiSystems
Peptide Institute
Immunocure
Cusabio
CSBio
CPC Scientific
Buchi
Bachem AG
Aurigene Pharmaceutical Services
AmbioPharm
ABZENA PLC
Peptide CRO Services Segment by Type
Modified Peptide Synthesis
Linear Peptide Synthesis
Cyclic Peptide Synthesis
Others
Peptide CRO Services Segment by Application
Pharmaceutical Companies
Biological Laboratories
Others
Peptide CRO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide CRO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peptide CRO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Peptide CRO Services Revenue Market Share by Type (2021-2026)
Table 7. Global Peptide CRO Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Peptide CRO Services Revenue Market Share by Type (2027-2032)
Table 9. Global Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Peptide CRO Services Revenue Market Share by Application (2021-2026)
Table 11. Global Peptide CRO Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Peptide CRO Services Revenue Market Share by Application (2027-2032)
Table 13. Global Peptide CRO Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Peptide CRO Services Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Peptide CRO Services Market Share by Region (2021-2026)
Table 16. Global Peptide CRO Services Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Peptide CRO Services Market Share by Region (2027-2032)
Table 18. Peptide CRO Services Industry Trends
Table 19. Peptide CRO Services Industry Drivers
Table 20. Peptide CRO Services Industry Opportunities and Challenges
Table 21. Peptide CRO Services Market Restraints
Table 22. Global Top Peptide CRO Services Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Peptide CRO Services Revenue Market Share by Players (2021-2026)
Table 24. Global Peptide CRO Services Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Peptide CRO Services, Headquarters and Area Served
Table 26. Global Peptide CRO Services Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Peptide CRO Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Peptide CRO Services Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Peptide CRO Services Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Peptide CRO Services Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Peptide CRO Services Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Peptide CRO Services Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Peptide CRO Services Market Size by Country (2027-2032) & (US$ Million)
Table 45. IMED Bioscience Company Information
Table 46. IMED Bioscience Business Overview
Table 47. IMED Bioscience Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 48. IMED Bioscience Peptide CRO Services Product Portfolio
Table 49. IMED Bioscience Recent Developments
Table 50. Peptites Biotech Company Information
Table 51. Peptites Biotech Business Overview
Table 52. Peptites Biotech Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 53. Peptites Biotech Peptide CRO Services Product Portfolio
Table 54. Peptites Biotech Recent Developments
Table 55. Genevoyager Company Information
Table 56. Genevoyager Business Overview
Table 57. Genevoyager Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 58. Genevoyager Peptide CRO Services Product Portfolio
Table 59. Genevoyager Recent Developments
Table 60. Viva Biotech Company Information
Table 61. Viva Biotech Business Overview
Table 62. Viva Biotech Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 63. Viva Biotech Peptide CRO Services Product Portfolio
Table 64. Viva Biotech Recent Developments
Table 65. Space Peptides Pharmaceutical Company Information
Table 66. Space Peptides Pharmaceutical Business Overview
Table 67. Space Peptides Pharmaceutical Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 68. Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio
Table 69. Space Peptides Pharmaceutical Recent Developments
Table 70. Motif Biotechnology Company Information
Table 71. Motif Biotechnology Business Overview
Table 72. Motif Biotechnology Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 73. Motif Biotechnology Peptide CRO Services Product Portfolio
Table 74. Motif Biotechnology Recent Developments
Table 75. JYMed Technology Company Information
Table 76. JYMed Technology Business Overview
Table 77. JYMed Technology Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 78. JYMed Technology Peptide CRO Services Product Portfolio
Table 79. JYMed Technology Recent Developments
Table 80. GenScript Company Information
Table 81. GenScript Business Overview
Table 82. GenScript Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 83. GenScript Peptide CRO Services Product Portfolio
Table 84. GenScript Recent Developments
Table 85. TriApex Laboratories Company Information
Table 86. TriApex Laboratories Business Overview
Table 87. TriApex Laboratories Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 88. TriApex Laboratories Peptide CRO Services Product Portfolio
Table 89. TriApex Laboratories Recent Developments
Table 90. Go Top Peptide Biotech Company Information
Table 91. Go Top Peptide Biotech Business Overview
Table 92. Go Top Peptide Biotech Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 93. Go Top Peptide Biotech Peptide CRO Services Product Portfolio
Table 94. Go Top Peptide Biotech Recent Developments
Table 95. Sun-Novo Pharmaceutical Research Company Information
Table 96. Sun-Novo Pharmaceutical Research Business Overview
Table 97. Sun-Novo Pharmaceutical Research Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 98. Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio
Table 99. Sun-Novo Pharmaceutical Research Recent Developments
Table 100. Thermo Fisher Company Information
Table 101. Thermo Fisher Business Overview
Table 102. Thermo Fisher Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 103. Thermo Fisher Peptide CRO Services Product Portfolio
Table 104. Thermo Fisher Recent Developments
Table 105. Syngene Company Information
Table 106. Syngene Business Overview
Table 107. Syngene Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 108. Syngene Peptide CRO Services Product Portfolio
Table 109. Syngene Recent Developments
Table 110. Svar Life Science Company Information
Table 111. Svar Life Science Business Overview
Table 112. Svar Life Science Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 113. Svar Life Science Peptide CRO Services Product Portfolio
Table 114. Svar Life Science Recent Developments
Table 115. PolyPeptide Company Information
Table 116. PolyPeptide Business Overview
Table 117. PolyPeptide Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 118. PolyPeptide Peptide CRO Services Product Portfolio
Table 119. PolyPeptide Recent Developments
Table 120. PeptiSystems Company Information
Table 121. PeptiSystems Business Overview
Table 122. PeptiSystems Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 123. PeptiSystems Peptide CRO Services Product Portfolio
Table 124. PeptiSystems Recent Developments
Table 125. Peptide Institute Company Information
Table 126. Peptide Institute Business Overview
Table 127. Peptide Institute Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 128. Peptide Institute Peptide CRO Services Product Portfolio
Table 129. Peptide Institute Recent Developments
Table 130. Immunocure Company Information
Table 131. Immunocure Business Overview
Table 132. Immunocure Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 133. Immunocure Peptide CRO Services Product Portfolio
Table 134. Immunocure Recent Developments
Table 135. Cusabio Company Information
Table 136. Cusabio Business Overview
Table 137. Cusabio Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 138. Cusabio Peptide CRO Services Product Portfolio
Table 139. Cusabio Recent Developments
Table 140. CSBio Company Information
Table 141. CSBio Business Overview
Table 142. CSBio Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 143. CSBio Peptide CRO Services Product Portfolio
Table 144. CSBio Recent Developments
Table 145. CPC Scientific Company Information
Table 146. CPC Scientific Business Overview
Table 147. CPC Scientific Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 148. CPC Scientific Peptide CRO Services Product Portfolio
Table 149. CPC Scientific Recent Developments
Table 150. Buchi Company Information
Table 151. Buchi Business Overview
Table 152. Buchi Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 153. Buchi Peptide CRO Services Product Portfolio
Table 154. Buchi Recent Developments
Table 155. Bachem AG Company Information
Table 156. Bachem AG Business Overview
Table 157. Bachem AG Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 158. Bachem AG Peptide CRO Services Product Portfolio
Table 159. Bachem AG Recent Developments
Table 160. Aurigene Pharmaceutical Services Company Information
Table 161. Aurigene Pharmaceutical Services Business Overview
Table 162. Aurigene Pharmaceutical Services Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 163. Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio
Table 164. Aurigene Pharmaceutical Services Recent Developments
Table 165. AmbioPharm Company Information
Table 166. AmbioPharm Business Overview
Table 167. AmbioPharm Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 168. AmbioPharm Peptide CRO Services Product Portfolio
Table 169. AmbioPharm Recent Developments
Table 170. ABZENA PLC Company Information
Table 171. ABZENA PLC Business Overview
Table 172. ABZENA PLC Revenue in Peptide CRO Services Business (2021-2026) & (US$ Million)
Table 173. ABZENA PLC Peptide CRO Services Product Portfolio
Table 174. ABZENA PLC Recent Developments
Table 175. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Peptide CRO Services Product Image
Figure 5. Global Peptide CRO Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Peptide CRO Services Market Share by Type: 2025 VS 2032
Figure 7. Modified Peptide Synthesis Product
Figure 8. Linear Peptide Synthesis Product
Figure 9. Cyclic Peptide Synthesis Product
Figure 10. Others Product
Figure 11. Global Peptide CRO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Peptide CRO Services Market Share by Application: 2025 VS 2032
Figure 13. Pharmaceutical Companies Product
Figure 14. Biological Laboratories Product
Figure 15. Others Product
Figure 16. Global Peptide CRO Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Peptide CRO Services Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Peptide CRO Services Market Share by Region: 2025 VS 2032
Figure 19. Global Peptide CRO Services Market Share by Players in 2025
Figure 20. Global Peptide CRO Services Manufacturers Established Date
Figure 21. Global Top 5 and 10 Peptide CRO Services Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America Peptide CRO Services Market Share by Country (2021-2032)
Figure 25. United States Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico Peptide CRO Services Market Share by Country (2021-2032)
Figure 28. Europe Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe Peptide CRO Services Market Share by Country (2021-2032)
Figure 30. Germany Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Peptide CRO Services Market Share by Country (2021-2032)
Figure 40. China Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Peptide CRO Services Market Share by Country (2021-2032)
Figure 45. Australia Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Peptide CRO Services Market Share by Country (2021-2032)
Figure 50. Brazil Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru Peptide CRO Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. IMED Bioscience Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 56. Peptites Biotech Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 57. Genevoyager Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 58. Viva Biotech Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 59. Space Peptides Pharmaceutical Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 60. Motif Biotechnology Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 61. JYMed Technology Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 62. GenScript Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 63. TriApex Laboratories Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 64. Go Top Peptide Biotech Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 65. Sun-Novo Pharmaceutical Research Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 66. Thermo Fisher Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 67. Syngene Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 68. Svar Life Science Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 69. PolyPeptide Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 70. PeptiSystems Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 71. Peptide Institute Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 72. Immunocure Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 73. Cusabio Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 74. CSBio Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 75. CPC Scientific Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 76. Buchi Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 77. Bachem AG Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 78. Aurigene Pharmaceutical Services Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 79. AmbioPharm Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Figure 80. ABZENA PLC Revenue Growth Rate in Peptide CRO Services Business (2021-2026)
Scope & coverage.
Types
- Modified Peptide Synthesis
- Linear Peptide Synthesis
- Cyclic Peptide Synthesis
- Others
Applications
- Pharmaceutical Companies
- Biological Laboratories
- Others
Companies covered
- IMED Bioscience
- Peptites Biotech
- Genevoyager
- Viva Biotech
- Space Peptides Pharmaceutical
- Motif Biotechnology
- JYMed Technology
- GenScript
- TriApex Laboratories
- Go Top Peptide Biotech
- Sun-Novo Pharmaceutical Research
- Thermo Fisher
- Syngene
- Svar Life Science
- PolyPeptide
- PeptiSystems
- Peptide Institute
- Immunocure
- Cusabio
- CSBio
- CPC Scientific
- Buchi
- Bachem AG
- Aurigene Pharmaceutical Services
- AmbioPharm
- ABZENA PLC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Peptide CRO Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Modified Peptide Synthesis
- 2.2.3 Linear Peptide Synthesis
- 2.2.4 Cyclic Peptide Synthesis
- 2.2.5 Others
- 2.3 Peptide CRO Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biological Laboratories
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Peptide CRO Services Breakdown Data by Type
- 3.1 Global Peptide CRO Services Historic Market Size by Type (2021-2026)
- 3.2 Global Peptide CRO Services Forecasted Market Size by Type (2027-2032)
4 Peptide CRO Services Breakdown Data by Application
- 4.1 Global Peptide CRO Services Historic Market Size by Application (2021-2026)
- 4.2 Global Peptide CRO Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Peptide CRO Services Market Perspective (2021-2032)
- 5.2 Global Peptide CRO Services Growth Trends by Region
- 5.2.1 Global Peptide CRO Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Peptide CRO Services Historic Market Size by Region (2021-2026)
- 5.2.3 Peptide CRO Services Forecasted Market Size by Region (2027-2032)
- 5.3 Peptide CRO Services Market Dynamics
- 5.3.1 Peptide CRO Services Industry Trends
- 5.3.2 Peptide CRO Services Market Drivers
- 5.3.3 Peptide CRO Services Market Challenges
- 5.3.4 Peptide CRO Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Peptide CRO Services Players by Revenue
- 6.1.1 Global Top Peptide CRO Services Players by Revenue (2021-2026)
- 6.1.2 Global Peptide CRO Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Peptide CRO Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Peptide CRO Services Head Office and Area Served
- 6.4 Global Peptide CRO Services Players, Product Type & Application
- 6.5 Global Peptide CRO Services Manufacturers Established Date
- 6.6 Global Peptide CRO Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Peptide CRO Services Market Size (2021-2032)
- 7.2 North America Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Peptide CRO Services Market Size by Country (2021-2026)
- 7.4 North America Peptide CRO Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Peptide CRO Services Market Size (2021-2032)
- 8.2 Europe Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Peptide CRO Services Market Size by Country (2021-2026)
- 8.4 Europe Peptide CRO Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Peptide CRO Services Market Size (2021-2032)
- 9.2 Asia-Pacific Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Peptide CRO Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Peptide CRO Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Peptide CRO Services Market Size (2021-2032)
- 10.2 South America Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Peptide CRO Services Market Size by Country (2021-2026)
- 10.4 South America Peptide CRO Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Peptide CRO Services Market Size (2021-2032)
- 11.2 Middle East & Africa Peptide CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Peptide CRO Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Peptide CRO Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IMED Bioscience
- 12.1.1 IMED Bioscience Company Information
- 12.1.2 IMED Bioscience Business Overview
- 12.1.3 IMED Bioscience Revenue in Peptide CRO Services Business (2021-2026)
- 12.1.4 IMED Bioscience Peptide CRO Services Product Portfolio
- 12.1.5 IMED Bioscience Recent Developments
- 12.2 Peptites Biotech
- 12.2.1 Peptites Biotech Company Information
- 12.2.2 Peptites Biotech Business Overview
- 12.2.3 Peptites Biotech Revenue in Peptide CRO Services Business (2021-2026)
- 12.2.4 Peptites Biotech Peptide CRO Services Product Portfolio
- 12.2.5 Peptites Biotech Recent Developments
- 12.3 Genevoyager
- 12.3.1 Genevoyager Company Information
- 12.3.2 Genevoyager Business Overview
- 12.3.3 Genevoyager Revenue in Peptide CRO Services Business (2021-2026)
- 12.3.4 Genevoyager Peptide CRO Services Product Portfolio
- 12.3.5 Genevoyager Recent Developments
- 12.4 Viva Biotech
- 12.4.1 Viva Biotech Company Information
- 12.4.2 Viva Biotech Business Overview
- 12.4.3 Viva Biotech Revenue in Peptide CRO Services Business (2021-2026)
- 12.4.4 Viva Biotech Peptide CRO Services Product Portfolio
- 12.4.5 Viva Biotech Recent Developments
- 12.5 Space Peptides Pharmaceutical
- 12.5.1 Space Peptides Pharmaceutical Company Information
- 12.5.2 Space Peptides Pharmaceutical Business Overview
- 12.5.3 Space Peptides Pharmaceutical Revenue in Peptide CRO Services Business (2021-2026)
- 12.5.4 Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio
- 12.5.5 Space Peptides Pharmaceutical Recent Developments
- 12.6 Motif Biotechnology
- 12.6.1 Motif Biotechnology Company Information
- 12.6.2 Motif Biotechnology Business Overview
- 12.6.3 Motif Biotechnology Revenue in Peptide CRO Services Business (2021-2026)
- 12.6.4 Motif Biotechnology Peptide CRO Services Product Portfolio
- 12.6.5 Motif Biotechnology Recent Developments
- 12.7 JYMed Technology
- 12.7.1 JYMed Technology Company Information
- 12.7.2 JYMed Technology Business Overview
- 12.7.3 JYMed Technology Revenue in Peptide CRO Services Business (2021-2026)
- 12.7.4 JYMed Technology Peptide CRO Services Product Portfolio
- 12.7.5 JYMed Technology Recent Developments
- 12.8 GenScript
- 12.8.1 GenScript Company Information
- 12.8.2 GenScript Business Overview
- 12.8.3 GenScript Revenue in Peptide CRO Services Business (2021-2026)
- 12.8.4 GenScript Peptide CRO Services Product Portfolio
- 12.8.5 GenScript Recent Developments
- 12.9 TriApex Laboratories
- 12.9.1 TriApex Laboratories Company Information
- 12.9.2 TriApex Laboratories Business Overview
- 12.9.3 TriApex Laboratories Revenue in Peptide CRO Services Business (2021-2026)
- 12.9.4 TriApex Laboratories Peptide CRO Services Product Portfolio
- 12.9.5 TriApex Laboratories Recent Developments
- 12.10 Go Top Peptide Biotech
- 12.10.1 Go Top Peptide Biotech Company Information
- 12.10.2 Go Top Peptide Biotech Business Overview
- 12.10.3 Go Top Peptide Biotech Revenue in Peptide CRO Services Business (2021-2026)
- 12.10.4 Go Top Peptide Biotech Peptide CRO Services Product Portfolio
- 12.10.5 Go Top Peptide Biotech Recent Developments
- 12.11 Sun-Novo Pharmaceutical Research
- 12.11.1 Sun-Novo Pharmaceutical Research Company Information
- 12.11.2 Sun-Novo Pharmaceutical Research Business Overview
- 12.11.3 Sun-Novo Pharmaceutical Research Revenue in Peptide CRO Services Business (2021-2026)
- 12.11.4 Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio
- 12.11.5 Sun-Novo Pharmaceutical Research Recent Developments
- 12.12 Thermo Fisher
- 12.12.1 Thermo Fisher Company Information
- 12.12.2 Thermo Fisher Business Overview
- 12.12.3 Thermo Fisher Revenue in Peptide CRO Services Business (2021-2026)
- 12.12.4 Thermo Fisher Peptide CRO Services Product Portfolio
- 12.12.5 Thermo Fisher Recent Developments
- 12.13 Syngene
- 12.13.1 Syngene Company Information
- 12.13.2 Syngene Business Overview
- 12.13.3 Syngene Revenue in Peptide CRO Services Business (2021-2026)
- 12.13.4 Syngene Peptide CRO Services Product Portfolio
- 12.13.5 Syngene Recent Developments
- 12.14 Svar Life Science
- 12.14.1 Svar Life Science Company Information
- 12.14.2 Svar Life Science Business Overview
- 12.14.3 Svar Life Science Revenue in Peptide CRO Services Business (2021-2026)
- 12.14.4 Svar Life Science Peptide CRO Services Product Portfolio
- 12.14.5 Svar Life Science Recent Developments
- 12.15 PolyPeptide
- 12.15.1 PolyPeptide Company Information
- 12.15.2 PolyPeptide Business Overview
- 12.15.3 PolyPeptide Revenue in Peptide CRO Services Business (2021-2026)
- 12.15.4 PolyPeptide Peptide CRO Services Product Portfolio
- 12.15.5 PolyPeptide Recent Developments
- 12.16 PeptiSystems
- 12.16.1 PeptiSystems Company Information
- 12.16.2 PeptiSystems Business Overview
- 12.16.3 PeptiSystems Revenue in Peptide CRO Services Business (2021-2026)
- 12.16.4 PeptiSystems Peptide CRO Services Product Portfolio
- 12.16.5 PeptiSystems Recent Developments
- 12.17 Peptide Institute
- 12.17.1 Peptide Institute Company Information
- 12.17.2 Peptide Institute Business Overview
- 12.17.3 Peptide Institute Revenue in Peptide CRO Services Business (2021-2026)
- 12.17.4 Peptide Institute Peptide CRO Services Product Portfolio
- 12.17.5 Peptide Institute Recent Developments
- 12.18 Immunocure
- 12.18.1 Immunocure Company Information
- 12.18.2 Immunocure Business Overview
- 12.18.3 Immunocure Revenue in Peptide CRO Services Business (2021-2026)
- 12.18.4 Immunocure Peptide CRO Services Product Portfolio
- 12.18.5 Immunocure Recent Developments
- 12.19 Cusabio
- 12.19.1 Cusabio Company Information
- 12.19.2 Cusabio Business Overview
- 12.19.3 Cusabio Revenue in Peptide CRO Services Business (2021-2026)
- 12.19.4 Cusabio Peptide CRO Services Product Portfolio
- 12.19.5 Cusabio Recent Developments
- 12.20 CSBio
- 12.20.1 CSBio Company Information
- 12.20.2 CSBio Business Overview
- 12.20.3 CSBio Revenue in Peptide CRO Services Business (2021-2026)
- 12.20.4 CSBio Peptide CRO Services Product Portfolio
- 12.20.5 CSBio Recent Developments
- 12.21 CPC Scientific
- 12.21.1 CPC Scientific Company Information
- 12.21.2 CPC Scientific Business Overview
- 12.21.3 CPC Scientific Revenue in Peptide CRO Services Business (2021-2026)
- 12.21.4 CPC Scientific Peptide CRO Services Product Portfolio
- 12.21.5 CPC Scientific Recent Developments
- 12.22 Buchi
- 12.22.1 Buchi Company Information
- 12.22.2 Buchi Business Overview
- 12.22.3 Buchi Revenue in Peptide CRO Services Business (2021-2026)
- 12.22.4 Buchi Peptide CRO Services Product Portfolio
- 12.22.5 Buchi Recent Developments
- 12.23 Bachem AG
- 12.23.1 Bachem AG Company Information
- 12.23.2 Bachem AG Business Overview
- 12.23.3 Bachem AG Revenue in Peptide CRO Services Business (2021-2026)
- 12.23.4 Bachem AG Peptide CRO Services Product Portfolio
- 12.23.5 Bachem AG Recent Developments
- 12.24 Aurigene Pharmaceutical Services
- 12.24.1 Aurigene Pharmaceutical Services Company Information
- 12.24.2 Aurigene Pharmaceutical Services Business Overview
- 12.24.3 Aurigene Pharmaceutical Services Revenue in Peptide CRO Services Business (2021-2026)
- 12.24.4 Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio
- 12.24.5 Aurigene Pharmaceutical Services Recent Developments
- 12.25 AmbioPharm
- 12.25.1 AmbioPharm Company Information
- 12.25.2 AmbioPharm Business Overview
- 12.25.3 AmbioPharm Revenue in Peptide CRO Services Business (2021-2026)
- 12.25.4 AmbioPharm Peptide CRO Services Product Portfolio
- 12.25.5 AmbioPharm Recent Developments
- 12.26 ABZENA PLC
- 12.26.1 ABZENA PLC Company Information
- 12.26.2 ABZENA PLC Business Overview
- 12.26.3 ABZENA PLC Revenue in Peptide CRO Services Business (2021-2026)
- 12.26.4 ABZENA PLC Peptide CRO Services Product Portfolio
- 12.26.5 ABZENA PLC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst